THE timing was precise, the choreography immaculate: with two deft maneuvres, a new generation of the Oeri-Hoffmann family marked its growing influence over the wealthiest dynasty in Switzerland.
First, seven members of the fifth generation late last year joined the clan’s shareholder pool, which oversees a US$25bil stake in pharmaceuticals giant Roche Holding AG. Then, in March, another member of that generation, Joerg Duschmale, replaced his uncle on the drugmaker’s board.
Already a subscriber? Log in
5.5 PAYDAY OFFER: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
